Human medicines European public assessment report (EPAR): Tavlesse, fostamatinib, Date of authorisation: 09/01/2020, Revision: 6, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 2 December 2024 - 16:26

Human medicines European public assessment report (EPAR): Tavlesse, fostamatinib, Date of authorisation: 09/01/2020, Revision: 6, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/tavlesse

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters